Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Canopy Growth earnings were much worse than views. The Canadian marijuana producer said it'll now focus on "select priority markets.

Canopy Growth Announces 'Strategy Reset' After Huge Q4 Loss; Marijuana Stocks Fall

The pot stock's been struggling over the past year, but there are plenty of reasons to be optimistic about its future.

4 Reasons Why Canopy Growth Could Bounce Back in 2020

Canopy Growth has rallied from March lows along with other cannabis stocks. As the sector shows signs of life, Canopy earnings need to be solid.

Expect Canopy Growth Stock to Pass Its Big Earnings Test

The largest pot stock in the world is set to report its fiscal fourth-quarter and full-year results on May 29.

Canopy Growth's Q4 Report: 5 Numbers You'll Want to Know

Canopy Growth Corp. CGC, +3.03% WEED, -5.88% will beat sales estimates when it reports March quarter earnings on Friday, but the stock may benefit more from clear guidance on EBITDA and cash flow, Cantor Fitzgerald said Wednesday.

Canopy Growth is seen beating March quarter sales, but EBITDA and cash flow guidance are key for stock: Cantor

Aurora Cannabis

Aphria

Cronos Group

Curaleaf Holdings, Inc.

HEXO Corp

Tilray Brands

Marijuana stocks are already getting buying interest ahead of the major event

7 Marijuana Stocks to Watch as the Presidential Election Approaches

The coronavirus pandemic could be a catalyst for the marijuana stocks in more ways than one. Here's why CGC stock is rallying again.

Why Canopy Growth Stock Is Surging Once Again

Canopy Growth (CGC) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

Canopy Growth (CGC) in Focus: Stock Moves 6.4% Higher

Green Thumb Industries Inc.

Which stock wins in a matchup between the biggest Canadian cannabis producer and one of the biggest U.S. cannabis operators?

Better Marijuana Stock: Canopy Growth vs. Green Thumb Industries

Alibaba

Beyond Meat

Alibaba, Canopy Growth, Cronos Group and Beyond Meat were our top stock trades for Tuesday. Let's look at the charts.

4 Top Stock Trades for Tuesday: BABA, BYND, CGC, CRON

Although the Canadian cannabis market has evolved more slowly than expected, Canopy Growth Corp (NYSE: CGC) has the potential to become a long-term leader in this sector, according to BofA Securities.

Canopy Growth Set To Become Cannabis Sector Leader, Says BofA

Amplify Alternative Harvest ETF

Cannabis company stocks are skyrocketing as investors are high on new hopes that marijuana might help ward off the deadly coronavirus.

Cannabis stocks soar on hopes pot wards off coronavirus

Canopy Growth and Cronos Group have more cash on hand than most other cannabis companies, but are they buys?

These 2 Pot Stocks Have the Most Cash to Weather the Downturn

Despite being the first industrialized country to legalize adult-use pot in the modern era, Canada's ambitions of being a marijuana leader have gone up in smoke.

Here's How Canada Blew Its Chance to Be a Cannabis Leader

In the upcoming earnings results, investors would like to see a clear path to profitability and an end to the current rate of cash burn
The post Canopy Growth Stock Doesn’t Look Ready for a Post-Earnings Pop appeared first on InvestorPlace.
More From InvestorPlace
		
					
				
					Top Stock Picker Reveals His Next 1,000% Winner				
			
					
				
					America’s Richest ZIP Code Holds Shocking Secret				
			
					
				
					#1 Under-the-Radar 5G Stock to Buy Now				
			
					
				
					The 1 Stock All Retirees Must Own

Canopy Growth Stock Doesn’t Look Ready for a Post-Earnings Pop

Constellation Brands

Canadian Canopy Growth is burning through cash way too quickly. That's why CGC stock is relying on Constellation Brands for survival.

Constellation Brands Must Exercise Warrants to Keep Canopy Growth Alive

CGC stock has plenty of risks in the near term but patient investors shouldn't lose sight of the fact that Canopy Growth is the best opportunity in cannabis.
The post Canopy Growth Is the Gold Standard in Cannabis appeared first on InvestorPlace.

Canopy Growth Is the Gold Standard in Cannabis

They might want to send a thank-you note to Aurora Cannabis.

Why Canopy Growth, Cronos Group, and OrganiGram Soared Today

Canopy Growth Corp (NYSE: CGC) shares are trading higher, potentially in sympathy with Aurora Cannabis (NYSE: ACB) following the company's earnings results.

Why Canopy Growth's Stock Is Trading Higher Today

Mallinckrodt PLC

Tivity Health

Indiscriminate sell-offs can sometimes lead to opportunities the crowds have missed. Here are three stocks that fit the criteria.

Top 3 Contrarian Stocks to Buy Right Now

Canopy Growth Corp (NYSE: CGC) has exercised warrants that matured May 1, received proceeds of CA$245 million ($174.5 million) and issued around 18.9 million shares, according to Cantor Fitzgerald.

Cantor Cuts Canopy Growth Target After Warrants Exercise

Two members of the marijuana company's C-suite depart for future endeavors.

2 Top Canopy Growth Executives Leave Company

The fact remains that it was always Constellation’s intention to make Canopy the fourth leg of its revenue stool to complement its beer, wine, and spirits businesses. I never thought Constellation would run away from its commitment to Canopy.

Canopy Growth Plays to Its Strengths for Future Growth

If anyone's wondering whether Constellation Brands is confident in its CGC stock holdings, here's your answer.
The post Is It Time to Join the Party and Double Down on Canopy Growth Stock?

Is It Time to Join the Party and Double Down on Canopy Growth Stock?

One pot stock has nearly tripled, while two others have walloped their shareholders.

News for Canopy Growth Stock (CGC)